Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

Harbor BioSciences, Inc. announced today that it has entered into an agreement with certain institutional investors to raise approximately $2.06 million in gross proceeds through the sale of approximately 5.9 million shares of its common stock and warrants to purchase approximately 3.5 million shares of its common stock.

7 Jun 2010

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the International Index of Erectile Function (IIEF) score.

7 Jun 2010

The Iacocca Family Foundation and Kineta partner to develop Type 1 diabetes mellitus drug

Kineta, Inc. joined with The Iacocca Family Foundation today to announce a new investment partnership to speed development of Kineta's preclinical autoimmune drug candidate - ShK-186 - and its multiple applications to treat Type 1 diabetes mellitus.

7 Jun 2010

Key regulator of fat cell differentiation identified

New research led by UCD Conway Fellow, Professor Johan Ericsson has identified a key regulator of fat cell differentiation that may be a novel target for obesity drugs. The results of the research are published in the current edition of the scientific journal, Proceedings of the National Academy of Sciences (PNAS).

4 Jun 2010

Researchers find a way to isolate pancreatic islet cells from brain dead donors using DI

A team of researchers from several collaborating Baylor University research centers and from Japan's Okayama Graduate School of Medicine have found a way to more consistently isolate pancreatic islet cells from brain dead donors using ductal injection, a process that immediately cools donor islet cells at the injection site.

4 Jun 2010

Testosterone deficiency can lead to multiple disorders

Almost a quarter of men treated for cancer in their childhood suffer from a deficiency of the male sex hormone testosterone.

3 Jun 2010

Community interventions help American Indian families reduce early childhood weight gain: Study

Community intervention can help American Indian families change behavior related to early childhood weight gain and obesity, according to a new Kaiser Permanente and Northwest Portland Area Indian Health Board study.

3 Jun 2010

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Entelos, Inc. has announced a publication in the peer-reviewed journal Clinical and Experimental Immunology describing the Type 1 Diabetes (T1D) PhysioLab® platform, an in silico solution for rapidly streamlining preclinical research through the evaluation of alternative scenarios for therapeutic strategies.

2 Jun 2010

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.

2 Jun 2010

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

Santarus, Inc., a specialty biopharmaceutical company, today announced that is has begun to enroll patients in the first study in its Phase III clinical program to evaluate the efficacy and safety of rifamycin SV MMX® for the treatment of patients with travelers' diarrhea.

2 Jun 2010

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

VIVUS, Inc. today announced that data from the previously reported phase 3 pivotal REVIVE (TA-301) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED), were presented at the American Urological Association (AUA) 2010 Annual Meeting.

2 Jun 2010

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

The New York Stem Cell Foundation (NYSCF) today announced the award of eight new NYSCF-Druckenmiller Fellows. These postdoctoral scientists join 15 accomplished stem cell researchers from leading institutions who have been supported by the program since 2006. NYSCF has awarded 23 fellowships to date.

2 Jun 2010

AAPA honors Idaho's Hal Joseph with 2010 PA Service to the Underserved Award

Hal Joseph, PA-C/CDE of Orofino, Idaho, received the American Academy of Physician Assistants' 2010 PA Service to the Underserved Award at the organization's 38th Annual Physician Assistant Conference in Atlanta yesterday. Joseph dedicated his career to helping those suffering from diabetes, a medical condition he has lived with since age 12, better manage their illness.

1 Jun 2010

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.

31 May 2010

Children watch more television if parents do

Children are more likely to watch high levels of television if their parents do, but parents do not need to be physically active to help their children to be active, a new study has found.

28 May 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

VIVUS, Inc. today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 inhibitor therapy being investigated for the treatment of erectile dysfunction, will be presented next Tuesday at the American Urological Association 2010 Annual Meeting in San Francisco, California.

28 May 2010

Good muscle mass, strength and diet needed to stave off diabetes

Sarcopenia - low skeletal muscle mass and strength - is often found in obese people and older adults; it has been hypothesized that sarcopenia puts individuals at risk for developing Type 2 diabetes.

28 May 2010

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.

27 May 2010

Abnormal androgen signaling in ovaries cause female infertility

Male sex hormones, such as testosterone, have well defined roles in male reproduction and prostate cancer. What may surprise many is that they also play an important role in female fertility. A new study finds that the presence and activity of male sex hormones in the ovaries helps regulate female fertility, likely by controlling follicle growth and development and preventing deterioration of follicles that contain growing eggs.

27 May 2010

IOM, UIC to convene regional meeting to discuss rising rates of diabetes, obesity in the U.S

The Institute of Medicine of the National Academies will convene a regional meeting on Sept. 21 at the University of Illinois at Chicago to discuss the rapidly rising rates of diabetes and obesity in the U.S.

27 May 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

The Iacocca Family Foundation and Kineta partner to develop Type 1 diabetes mellitus drug

Key regulator of fat cell differentiation identified

Researchers find a way to isolate pancreatic islet cells from brain dead donors using DI

Testosterone deficiency can lead to multiple disorders

Community interventions help American Indian families reduce early childhood weight gain: Study

Entelos' T1D PhysioLab platform published in Clinical and Experimental Immunology

Raptor Pharmaceutical acquires exclusive license to intellectual property for Huntington's Disease treatment

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

AAPA honors Idaho's Hal Joseph with 2010 PA Service to the Underserved Award

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Children watch more television if parents do

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

Good muscle mass, strength and diet needed to stave off diabetes

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

Abnormal androgen signaling in ovaries cause female infertility

IOM, UIC to convene regional meeting to discuss rising rates of diabetes, obesity in the U.S

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in